Fig. 4From: Bioinformatic analysis and experimental validation of cuproptosis-related LncRNA as a novel biomarker for prognosis and immunotherapy of oral squamous cell carcinomaSurvival curves for model validation. The prognostic model can be adopted for different clinical subgroups of OSCC: A, B Age (≤/>65 years). C, D Gender (female/male). E, F Clinical stage (I-II/III-IV). G, H, I Pathological grade (1, 2, 3), P < 0.05Back to article page